待处理
入排:排除
图源:待检查
Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Dermatol Ther (Heidelb) 15(4) 1037-1044
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板